Holocaust survivors experience elevated risk of cancer: Study

Image
ANI Washington D.C. [USA]
Last Updated : Jul 11 2017 | 1:57 PM IST

According to a new study, the survivors of the Holocaust experience a small but consistent increase in the risk of developing cancer.

Holocaust survivors were exposed to a variety of factors that have been linked with cancer.

The team studied 152,622 Holocaust survivors who were followed for more than 45 years. Two separate definitions of exposure were used. One definition was based on the individual's entitlement for compensation according to a set of laws.

The other was based on the country of origin, using a classification of countries during the war into those that were directly governed by Nazi Germany and other non-occupied countries.

Cancer was diagnosed in 22 percent of those who were granted compensation for suffering persecution during the war versus 16 percent of those who were denied compensation.

Survivors who were granted compensation had a six percent higher risk of developing any type of cancer than those who were denied compensation, and they had a 12 percent increased risk for colorectal cancer and a 37 percent increased risk for lung cancer.

Those born in occupied countries had an eight percent increased risk of developing any cancer than those born in non-occupied countries, as well as eight percent and 12 percent increased risks of colorectal cancer and lung cancer, respectively.

The investigators observed no elevated risks for breast cancer and gynecologic cancers among female survivors.

Professor Siegal Sadetzki, MD, MPH, of the Chaim Sheba Medical Center in Israel, shared, "The data emphasize the importance of learning about the combined effect of several exposures occurring intensely and contemporaneously on cancer risk, such as those that unfortunately occurred during World War II. Such inspection cannot be conducted by experimental studies and could only be evaluated by using observational epidemiological surveys."

The study was published in journal CANCER.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 11 2017 | 1:57 PM IST

Next Story